Diffusion Pharmaceuticals

$1.08
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+0.93%) As of 3:57 PM UTC today

Why Robinhood?

You can buy or sell DFFN and other stocks, options, and ETFs commission-free!

About DFFN

Diffusion Pharmaceuticals Inc. Common Stock, also called Diffusion Pharmaceuticals, is a clinical stage company, which engages in the development of treatment for life threatening conditions. It offers Trans Sodium Crocetinate. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA. The listed name for DFFN is Diffusion Pharmaceuticals Inc. Common Stock.

CEO

Robert J. Cobuzzi

Employees

Headquarters

Charlottesville, Virginia

Founded

2001

Market Cap

75.12M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

5.81M

High Today

$1.16

Low Today

$1.07

Open Price

$1.15

Volume

1.39M

52 Week High

$1.60

52 Week Low

$0.25

Collections

DFFN Earnings

-$0.63

-$0.34

-$0.04

$0.25

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

Expected Mar 17, After Hours